The U.S. government is soliciting bids to acquire $3.4 billion worth of nuclear fuel. As the biggest uranium producer in North America, Cameco is a logical beneficiary.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?